In Vivo Relevancy of Three-Dimensional Cardiomyocyte Cell Culture Models
Mike Johnson2019-11-20T08:49:48-05:00In the drug discovery field, we typically work from high-throughput and low cost assays with poor in vivo relevancy [...]
Taking Advantage of Advances in Computer Hardware for Image Quantification
Mike Johnson2019-11-20T09:05:37-05:00Here at Visikol, image analysis is a central pillar of our experimental process, and how we turn complex in [...]
How to Design Your In Vitro Disease Model
Mike Johnson2019-11-20T08:12:34-05:00Choosing the appropriate amount of complexity to answer your biological question is critical when designing a disease model. The [...]
State of the 3D Cell Culture Field and Drug Discovery
Five years ago, the field of 3D cell culture was primarily an academic pursuit with graduate students and post [...]
Barriers to Adopting Machine Learning and Digital Pathology in the Clinic
As a leading provider of digital pathology services and solutions, we have worked with dozens of pharmaceutical companies in [...]
Blog Post: Pre-clinical Ophthalmology Services
Visikol is a contract research organization that provides researchers at academic institutions and pharmaceutical companies with unique services in [...]
Come Visit Visikol at the Liver Meeting in Boston at Booth 331 from Nov 9-11
This year's Liver Meeting will be the 70th annual meeting of the American Association for the Study of Liver Diseases [...]
Cell Viability Assays for 3D Cell Culture
One of the most common assays used with in vitro models is an assessment of total ATP which is [...]
Visikol Expands Image Analysis as a Service Capabilities
Visikol is one of the leading providers of digital pathology services and partners with researchers to assist them in [...]
Applying Deep Learning to Bio-Imaging and Digital Pathology
Bioimaging is the subfield of biology that focuses primarily on capturing images or video of biological processes, commonly at [...]